Transcat price target raised to $120 from $110 at Oppenheimer

Oppenheimer raised the firm’s price target on Transcat to $120 from $110 and keeps an Outperform rating on the shares. The firm notes the company’s Q3 is another solid showcase of management execution and its business momentum. Oppenheimer remains confident in its thesis of sustained revenue growth and margin expansion.